Remdesivir: US buys world stock of key coronavirus drug

Trump administration goes on shopping spree leaving ‘nothing for Europe’

remdesivir
(Image credit: (Ulrich Perrey/Pool/AFP via Getty Images))

The US has bought the global stock of the key coronavirus drug remdesivir, leaving none for the UK, Europe or most of the rest of the world.

Remdesivir is the first drug approved by licensing authorities in the US to treat Covid-19, and one of just two drugs worldwide proven to combat the virus.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us